NCT03387033View on ClinicalTrials.gov

Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)

NATerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

April 25, 2019

Study Completion Date

April 25, 2019

Conditions
Sickle Cell DiseaseVirtual RealityAnxietyDepressionCancer
Interventions
DEVICE

Relaxation response and virtual reality (VR) session

A 10-minute relaxation response (mindfulness and deep breathing) followed by 10-minute immersive VR session.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT03387033 - Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD) | Biotech Hunter | Biotech Hunter